Hans Bøtker

Showing 1-19 of 19 articles

Coronary interventions

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Pareek M, Madsen M, Warnakula Olesen K, Okkels Jensen L, Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker H, Maeng M

December 6, 2019 | 10.4244/EIJ-D-19-00503

Other coronary interventions

Plaque burden influences accurate classification of fibrous cap atheroma by in vivo optical coherence tomography in a porcine model of advanced coronary atherosclerosis

Poulsen CB, Pedrigi RM, Pareek N, Kilic D, Holm N.R., Bentzon JF, Bøtker H, Falk E, Krams R, De Silva R

November 20, 2018 | 10.4244/EIJ-D-17-01028

STEMI

One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis

Hansen KN, Bendix K, Antonsen L, Veien K, Maeng M, Junker A, Christiansen E, Kahlert J, Terkelsen C, Christensen LB, Fallesen C, Bøtker H, Okkels Jensen L

October 19, 2018 | 10.4244/EIJ-D-17-00800

Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)

Okkels Jensen L, Maeng M, Raungaard B, Hansen K, Kahlert J, Jensen S, Hansen H, Flensted Lassen J, Bøtker H, Christiansen E

January 19, 2018 | 10.4244/EIJ-D-17-00731

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents

Jakobsen L, Christiansen E, Maeng M, Hansen K, Kristensen SD, Bøtker H, Terkelsen C, Jensen S, Raungaard B, Madsen M, Flensted Lassen J, Okkels Jensen L

December 20, 2017 | 10.4244/EIJ-D-17-00434

Coronary interventions

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker H, Clemmensen P, Køber L, Treiman M, Engstrøm T

July 20, 2016 | 10.4244/EIJV12I4A78

Feasibility and early safety of hybrid coronary revascularisation combining off-pump coronary surgery through J-hemisternotomy with percutaneous coronary intervention

Modrau I, Nielsen P, Bøtker H, Christiansen E, Krusell L, Kaltoft A, Terkelsen C, Kristensen SD, Flensted Lassen J, Thuesen L, Maeng M

February 20, 2015 | 10.4244/EIJV10I10A195

ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial infarction

Lønborg J, Kelbæk H, Engstrøm T, Helqvist S, Kløvgaard L, Holmvang L, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi N, Kaltoft A, Bøtker H, Clemmensen P, Terkelsen C

August 19, 2014 | 10.4244/EIJV10I4A80

Randomised comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study

Holm N.R., Sindberg B, Schou M, Maeng M, Kaltoft A, Bottcher M, Krusell L, Hjort J, Thuesen L, Terkelsen C, Christiansen E, Bøtker H, Kristensen SD, Flensted Lassen J

June 20, 2014 | 10.4244/EIJV10I2A31

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial

Antonsen L, Thayssen P, Hansen H, Maeng M, Tilsted H, Bøtker H, Ravkilde J, Madsen M, Sørensen H, Thuesen L, Flensted Lassen J, Okkels Jensen L

June 20, 2014 | 10.4244/EIJV10I2A35

Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study

Ruiz-Garc J, Lerman A, Weisz G, Maehara A, Mintz G, Fahy M, Xu K, Lansky A, Cristea E, Farah T, Teles R, Bøtker H, Templin B, Zhang Z, De Bruyne B, Serruys P, Stone G

December 28, 2012 | 10.4244/EIJV8I8A142

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial

Okkels Jensen L, Maeng M, Thayssen P, Villadsen A, Krusell L, Bøtker H, Pedersen K, Aaroe J, Christiansen E, Vesterlund T, Hansen K, Ravkilde J, Tilsted H, Flensted Lassen J, Thuesen L

July 29, 2011 | 10.4244/EIJV7I3A56

A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial

Kastrup J, Jørgensen E, Fuchs S, Nikol S, Bøtker H, Gyöngyösi M, Glogar D, Kornowski R

February 21, 2011

Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies

Thim T, Hagensen M, Drouet L, Sollier C, Bonneau M, Granada J, Nielsen L, Paaske W, Bøtker H, Falk E

June 30, 2010 | 10.4244/EIJV6I2A42

Efficiency and safety of the sirolimus eluting stent in complex coronary artery lesions after cessation of dual antiplatelet therapy: fifteen months clinical outcome of the randomised Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial

Helqvist S, Kelbæk H, Thuesen L, Kløvgaard L, Krusell L, Jørgensen E, Bøtker H, Jensen G, Flensted Lassen J, Thayssen P, Galloe A, Saunamäki K

November 20, 2007

Impact of drug eluting stents on target vessel revascularization. A report from the Western Denmark heart registry from 2000 to 2004.

Okkels Jensen L, Maeng M, Thayssen P, Flensted Lassen J, Bøtker H, Rasmussen K, Thuesen L

February 20, 2006

Outcome of unprotected left main percutaneous coronary intervention in surgical low-risk, surgical high-risk, and acute myocardial infarction patients

Christiansen E, Flensted Lassen J, Andersen H, Romer Krusell L, Dalby Kristensen S, Bøtker H, Thuesen L

February 20, 2006

Randomized comparison of deliverability and in-hospital complications in implantation of BxSonic®, Express® and Flexmaster® coronary stents

Thuesen L, Galloe A, Thayssen P, Rasmussen K, Kelbæk H, Flensted Lassen J, Hansen P, Pedersen K, Ravkilde J, Helqvist S, Abildgaard U, Andersen H, Bøtker H, Kristensen SD, Hjort J, Romer Krusell L

November 20, 2005

In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention

Thuesen L, Rud Andersen H, Bøtker H, Kristensen SD, Romer Krusell L, Flensted Lassen J

May 20, 2005

Latest news

NEW ISSUE

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

June 25, 2020

NEW

Ahead of print: EAPCI Core Curriculum for PCI (2020)

July 7, 2020

Editorial

IVUS guidance during left main PCI: not if, but when and how

Akiko Maehara

July 8, 2020

NEW

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

July 6, 2020

Editorial

Left main PCI: are we giving the kiss the attention it deserves?

July 8, 2020

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

July 1, 2020

JAA

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Hans Bøtker

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke